Clinical Trial Update: A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating TT125-802 in adults with advanced solid tumors, focusing on safety, tolerability, pharmacokinetics, and preliminary e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• TT125-802

Snippet

Sponsor: TOLREMO therapeutics AG | Conditions: Advanced Solid Tumor, Adult Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING